A nurse is caring for a client who has a history of coronary thrombosis and is taking warfarin as a long-term anticoagulant therapy. What laboratory test should the nurse monitor to evaluate the effectiveness of warfarin?
Activated partial thromboplastin time (aPTT)
International normalized ratio (INR)
Platelet count
Fibrinogen level.
The Correct Answer is B
The INR is a standardized measure of the prothrombin time (PT), which reflects the activity of the extrinsic and common pathways of coagulation.
Warfarin is an anticoagulant that inhibits the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X), which are involved in these pathways.
Therefore, the INR is used to monitor the effectiveness of warfarin therapy and adjust the dose accordingly. The target INR range depends on the indication for warfarin, but it is usually between 2 and 3.
Choice A is wrong because activated partial thromboplastin time (aPTT) reflects the activity of the intrinsic and common pathways of coagulation.
Heparin is an anticoagulant that enhances the activity of antithrombin, which inhibits factors II, IX, X, XI, and XII, which are involved in these pathways. Therefore, the aPTT is used to monitor the effectiveness of heparin therapy.
Choice C is wrong because platelet count measures the number of platelets in the blood, which are involved in primary hemostasis. Platelet count is not affected by warfarin therapy, but it can be decreased by heparin-induced thrombocytopenia (HIT), a rare but serious complication of heparin therapy.
Choice D is wrong because fibrinogen level measures the amount of fibrinogen in the blood, which is a precursor of fibrin, the main component of blood clots. Fibrinogen level is not affected by warfarin therapy, but it can be decreased by disseminated intravascular coagulation (DIC), a condition where widespread clotting and bleeding occur simultaneously.
The normal ranges for these tests are as follows:
• INR: 0.8 to 1.2
• aPTT: 25 to 35 seconds
• Platelet count: 150 to 450 x 10^9/L
• Fibrinogen level: 2 to 4 g/L
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","B","E"]
Explanation
Clopidogrel is an antiplatelet drug that inhibits the ability of platelets to clump together as part of a blood clot.It is used to prevent recurrent stroke and other cardiovascular events in people who are at high risk.
Choice A is correct because taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) while on clopidogrel can increase the risk of bleeding.These drugs also affect platelet function and can interfere with the action of clopidogrel.
Choice B is correct because bleeding is the most common side effect of clopidogrel.Any signs of bleeding, such as nosebleeds, bruising, or black stools, should be reported to the provider as they may indicate a serious complication.
Choice C is wrong because clopidogrel can be taken with or without food.Taking it with food does not prevent gastrointestinal upset, which is another possible side effect of clopidogrel.
Choice D is wrong because clopidogrel does not affect blood pressure.However, having high blood pressure can increase the risk of stroke and other cardiovascular events, so it is important to have it checked regularly and treated if necessary.
Choice E is correct because clopidogrel should be stopped at least 5 days before any planned surgery.This is to reduce the risk of excessive bleeding during or after the surgery.The provider should be informed about the use of clopidogrel and any other medications before undergoing any surgical procedure.
Correct Answer is B
Explanation
Subcutaneous injection in the abdomen.This is because enoxaparin is a low-molecular-weight heparin that is administered subcutaneously, usually in the abdomen or outer thigh.The drug should be clear and colorless or pale yellow.The dosage for adults is typically 30mg every 12 hours for 7 to 10 days, or 40mg once a day for 3 weeks after hip replacement surgery.The needle should be inserted fully into the skin and the syringe plunger should be pressed down to inject the drug.Injection sites should be rotated and areas of active skin disease or injury should be avoided.
Choice A is wrong because intramuscular injection in the deltoid muscle is not the recommended route or site for enoxaparin.Intramuscular injection may cause bleeding, bruising, or hematoma formation.
Choice C is wrong because intravenous infusion in a peripheral vein is not the recommended route for enoxaparin.Enoxaparin can be given intravenously only as a bolus injection for acute coronary syndrome, not as an infusion.
Choice D is wrong because intradermal injection in the forearm is not the recommended route or site for enoxaparin.Intradermal injection may cause skin irritation, infection, or necrosis.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.